Tissue kallikrein (TK) is secreted by serous cells of tracheobronchial submucosal glands and plays a role in allergic airway responses. To better understand the regulation of TK, we used primary cultures of submucosal gland cells that release TK upon stimulation. Media from cultures stimulated with chymase (10 Ϫ 7 M) showed increased TK activity (0.50 Ϯ 0.22 mU/ml mean Ϯ standard error) in comparison with the control group (0.08 Ϯ 0.02 mU/ml). The increased TK activity was significantly correlated with increases in the levels of the serous cell marker, secretory leukoprotease inhibitor. Anion exchange chromatography of the conditioned culture media showed that TK activity eluted as a broad peak between 1.6 and 1.8 M NaCl, unlike the reported elution (0.3 to 0.6 M NaCl) of kallikreins from other tissues, suggesting that secreted bronchial TK was bound to a negatively charged molecule. Hyaluronidase digestion increased TK activity in both pre-and post-chymase-stimulated culture media, whereas no such change was seen after samples were digested with heparinase or chondroitinase ABC. Further, after hyaluronidase digestion of media, TK eluted from an anion exchange column between 0.3 and 0.6 M NaCl. Enzymatic detection of TK after nondenaturing gel electrophoresis showed that hyaluronidase digestion also reduced the electrophoretic heterogeneity of TK to a single band, whereas adding back hyaluronic acid (HA) to hyaluronidase-digested samples restored the original heterogeneity. Finally, TK activity bound to HA-Sepharose and could be eluted with HA. These studies show that primary cultures of ovine submucosal gland cells secrete TK in a regulated fashion, and that secreted TK binds to HA. This binding reduces TK enzymatic activity; therefore, factors that affect HA turnover could modify the TK activity in the airway lumen. These events could be important in the regulation of kinin-mediated airway inflammation. 
Tissue kallikreins (TKs) (EC 3.4.21.35 ) are a family of serine proteinases that are involved in the post-transcriptional processing of polypeptide precursors to their biologically active form (1, 2) . TKs are secreted in a variety of glandular tissue, including salivary glands (3) (4) (5) , colon (4), stomach (6) , uterus (7), pituitary gland (8) , and pancreas (9) . It is also synthesized by neutrophils (10) , kidney (11) , and endothelial cells (12) . TK function and regulation varies with tissue localization (2) . For example, in the kidney, TK regulates local blood flow through kinin generation, and its expression is affected by NaCl intake (13) . In contrast, in pituitary glands TK expression is induced by estrogen (8) and its main function seems to be prolactin processing (14) . Thus, the variability in localization, regulation, and substrate specificity of TK (2) suggest that its characterization in the specific tissue of interest is necessary to fully understand its biologic functions.
TK has been identified as the major kininogenase in the airways (3) . TK proteolyzes both high and low molecularweight kininogen in a highly selective and limited fashion to yield lysyl-bradykinin (kallidin), a potent vasoactive peptide that influences a number of biologic processes including vasodilation, vascular permeability, and bronchoconstriction-all of which contribute to asthma pathophysiology. Immunohistochemical studies localize bronchial TK in the serous cells of submucosal glands of human and guinea pig trachea (15, 16) , and TK-like activity is increased in human nasal and bronchoalveolar lavage (BAL) after allergen challenge (17) (18) (19) , but its biochemical characteris-tics, as well as control mechanisms of synthesis and secretion, are poorly understood.
Studies from our laboratory using allergic sheep indicate that airway challenge with a wide range of inflammatory stimuli that cause bronchoconstriction and/or airway hyperresponsiveness (AHR), such as allergen, metabisulfite, ozone, and bacterial supernatants, are associated with increased concentrations of immunoreactive kinins and increased TK-like activity in BAL fluid (BALF) (15, (20) (21) (22) . That kinins contribute to these events is supported by the finding that bradykinin B 2 receptor antagonists can block the bronchoconstriction and airway hyperresponsiveness caused by these agents (23) (24) (25) (26) (27) .
Collectively, these observations indicate that in the lung, increased TK activity contributes to airway inflammation, which leads to bronchoconstriction and AHR. Therefore, understanding the mechanisms leading to the increased TK activity is important. Primary cultures from ovine tracheal gland cells were used in the present study to explore the regulation of bronchial TK activity and secretion.
Materials and Methods
All materials were purchased from Sigma Chemical Co. (St. Louis, MO) unless otherwise specified.
Primary Cultures of Tracheal Submucosal Gland Cells
Primary cultures of tracheal submucosal gland cells were prepared according to the method of Tournier and colleagues (28) with some modifications. Briefly, sheep trachea was cut in pieces and bathed in Dulbecco's modified Eagle's medium with 20 mM N -2-hydroxyethylpiperazine-N Ј -ethane sulfonic acid (DMEM) containing penicillin (100 U/ml), streptomycin (100 g/ml), and amphotericin (0.25 g/ml). The tracheal segments were cut longitudinally along the posterior membrane. The luminal surface was gently scraped with gauze and rinsed three times with DMEM to remove the surface epithelium. The tissue above the cartilage was dislodged, cut in pieces, rinsed twice with DMEM, and incubated with 0.1% protease (dispase from Bacillus polymyxa ) at 4 Њ C for 3 d. The tissue fragments were removed from the protease solution, scraped with a disposable cell scraper and vigorously shaken in DMEM containing 5% heat-deactivated fetal calf serum (FCS). The cell suspension was centrifuged at 150 ϫ g and resuspended in 50% DMEM and 50% Ham's Nutrient F-12 with 5% FCS. The cell suspension was plated on a Costar 24-well plate previously coated with collagen (type VI, 500 l/well, 0.05% in 0.2% acetic acid) and incubated for 24 h at room temperature (RT). The plates were then transferred into a 5% CO 2 humidified incubator at 37 Њ C for 24 h. The media were replaced with serum-free media made with 50% DMEM and 50% Ham's Nutrient F-12 containing insulin (10 g/ml; Collaborative Biomedical Products, Bedford, MA), transferrin (5 g/ml), endothelial cell growth supplement (7.5 g/ml; Collaborative Biomedical Products), triiodothyronine (20 ng/ml), penicillin (100 U/ml), streptomycin (100 g/ml), and amphotericin (0.25 g/ml) (28) . Plates were then incubated at 32 Њ C to promote the preferential growth of gland cells (29) , and the media changed daily. For the experiments, we used confluent monolayers that contained approximately 5 ϫ 10 5 cells per well (2 cm 2 ).
Stimulation of the Cultures with Chymase
For stimulation experiments, primary cultures of submucosal gland cells obtained from five sheep were used. To establish baseline secretion rates (28, 30) , confluent cultures were washed three times with phosphate-buffered saline (PBS) and twice with DMEM and incubated in RPMI 1640 without phenol red at 37 Њ C in a CO 2 humidified incubator for 24 h. The media were removed, and 400 l of RPMI were added to each well, and cultures were incubated under the same conditions for 90 min. This procedure was then repeated at the same intervals (28) . After collection of the media, the cultures were stimulated by adding 400 l of 10 Ϫ 7 M chymase (a gift from Dr. Richard Tanaka, Arris Pharmaceutical, San Francisco, CA) in RPMI. RPMI only (400 l) was added to control wells. Supernatants were collected 1.5 and 24 h after stimulation. All samples were centrifuged (250 ϫ g , 10 min at 4 ° C) and frozen at Ϫ 20 Њ C for further analysis.
TK Enzyme Activity
Activity was measured with a spectrophotometric assay using a synthetic peptide substrate that, in the presence of soybean trypsin inhibitor (SBTI), is highly specific for TK (31) with the exception of the mast-cell product tryptase. Mast cells are not present in our cultures, but mast-cell tryptase could be a contaminant in the chymase preparations. For that reason, we added the tryptase inhibitor APC 366 to SBTI. Briefly, in an ultralow-binding 96-well plate, samples (100 l) were incubated with 25 l of trypsin (5 g/ml) for 15 min at 37 Њ C to activate prokallikrein (1). After adding 25 l of SBTI (2 mg/ml) and 50 l of APC 366 (1 mg/ml; a gift from Dr. Richard Tanaka, Arris Pharmaceutical), 100 l of DL-Val-Leu-Arg-pNA (2 mM; ICN, Irvine, CA) in 200 mM Tris (pH 8.2) was added, and absorbance was monitored at 405 nm using a Dynatech MRX microplate reader. One enzyme unit was defined as one mole of substrate degraded per minute at pH 8.2 and 22 Њ C. Chymase showed no kallikrein-like activity in our assay.
Immunohistochemistry
Samples of tissue from trachea to bronchi of the fifth generation were fixed in 4% paraformaldehyde in PBS and embedded in paraffin. After rehydration using xylene, followed by decreasing concentrations of ethanol, slides were incubated in 3% hydrogen peroxide for 15 min to quench endogenous peroxidase activity, known to exist in goblet cells and submucosal glands (32, 33) . Slides were washed in PBS (5 min), blocked with 20% goat serum in PBS for 1 h and then incubated with an antibody to human urinary kallikrein (HUK) (1/1,000 in 20% goat serum, Calbiochem, La Jolla, CA) at 4 Њ C overnight. After washing in PBS (three times for 5 min each), slides were incubated with peroxidase-labeled goat antirabbit immunoglobulin (Ig)G (ABC kit; Vector Laboratories, Burlingame, CA) at RT for 30 min and washed with PBS (five times for 5 min each). Visualization was achieved by incubating with diaminobenzamidine (1 mg/ml) in PBS ϩ H 2 O 2 0.01% at RT for 8 min. Slides were washed, counterstained with Harris hematoxylin, dehydrated, and mounted. Controls omitting the first antibody were prepared identically.
Immunofluorescence
Primary cultures grown on glass coverslips were fixed in 4% paraformaldehyde in PBS (1 h), permeabilized with cold methanol ( Ϫ 20 Њ C, 10 min), washed in PBS (three times for 5 min each), and blocked with 20% goat serum at RT for 1 h. Blocking solution was removed and rabbit anti-HUK (1/500 in 20% goat serum) was added and incubated overnight at 4 Њ C.
After washing with PBS (three times for 10 min each), fluorescein-labeled antirabbit IgG was applied to the coverslips and incubated for 30 min at RT. Slides were washed with PBS, mounted in aqueous mounting medium (Slow Fade kit; Molecular Probes, Eugene, OR), and examined using a Nikon Labophot microscope.
Anion Exchange Chromatography
Conditioned cell culture medium (200 ml) was applied to an anion exchange column (1 ml UnoQ; Bio-Rad) previously equilibrated in 50 mM Tris (pH 8.0), 0.5% 3-(3-cholamidopropyl) dimethyl-ammonio-1 propanesulfonate (CHAPS), in 0.15 M NaCl at a 250-l/min flow rate. Washing was performed with equilibration buffer until absorbance at 280 nm (A 280 ) returned to baseline values. Elution was achieved with a gradient of 0.1 to 2.0 M NaCl in 50 mM Tris (pH 8.0, 0.5% CHAPS). A column was also run using conditioned media (150 ml) that had been digested with hyaluronidase (0.5 U/ml at 37 Њ C overnight). Chromatography was then performed as previously described, except that elution gradient was between 0.1 and 1.0 M NaCl.
Hyaluronic Acid Affinity Chromatography
Hyaluronic acid (HA) was cross-linked to activated Sepharose according to the method of Tengblad (20) with some modifications (34) . Briefly, 5 ml epoxy-activated hydrophilic (EAH)-Sepharose (Pharmacia, Uppsala, Sweden), 10 mg HA (Worthington, Freehold, NJ), and 0.5 g N -ethyl-N -(3-dimethylaminopropyl)-carbodiimide (Pierce, Rockford, IL) were mixed with 20 ml of distilled water and the pH was adjusted to 4.5. The mixture was rotated end-over-end at RT overnight. Beads were washed with 0.1 M Na acetate in 0.1 M NaCl (pH 4.0) and 0.1 M Tris in 0.5 M NaCl five times alternately and then equilibrated in PBS. The efficiency of the resulting HA-Sepharose was tested using a biotinylated HA-binding protein (bHABP), a gift from Dr. V. Lockeshwar, University of Miami. HA-Sepharose (100 l) was incubated with buffer and with 1, 10, 100, and 1,000 g of bHABP, and rotated end-over-end for 1 h at RT.
Samples were spun gently (30 ϫ g ) and supernatants were tested by dot blot using avidin-horseradish peroxidase (HRP). The resulting beads showed a binding capacity of at least 10 mg bHABP/ml. Newly prepared HASepharose was packed in a 5-ml column. The culture supernatants were pooled, and an aliquot (85 ml) was applied to the column at a flow rate of 200 l/min. After washing with 0.5 M NaCl in PBS, the column was eluted with HA (1 mg/ml, 0.5 M NaCl) in PBS. Another aliquot (20 ml) was run through a 1 ml heparin-Sepharose column (Sigma) as a negative control.
Detection of TK Activity in Acrylamide Gels
Using an overlay membrane method described by Smith (35) , samples were electrophoresed in 12% polyacrylamide gels (precast minigels; Bio-Rad) under nondenaturing conditions, followed by the application, on top of the gel, of a moist cellulose acetate membrane preimpregnated with DH-Val-Leu-Arg amidofluorocoumarin (AFC) (2 mM; Novabiochem, CA), in 4 mg/ml SBTI and 10 mM Tris (pH 8.2). After incubation for 30 min at 37 Њ C, the membrane was peeled off, examined under a long-wave ultraviolet lamp (365 nm), and photographed.
Glycosidase Digestion
Aliquots from pooled supernatants, obtained from unstimulated as well as chymase-stimulated cultures ( n ϭ 3) (500 l), were digested by incubation at 37 Њ C overnight with heparinase in PBS, ABC (ICN) in 100 mM Tris-Cl (pH 6.5), and hyaluronidase (Worthington) in 100 mM K-Acetate (pH 5.6), each at a concentration of 0.5 U/ml. All enzymatic digestions were done in the presence of a cocktail of protease inhibitors, consisting of leupeptin (10 Ϫ 7 M), pepstatin (0.1 g/ml), and SBTI (1 mg/ml), as well as ethylenediaminetetraacetic acid (EDTA) (1 mM). Controls were done using each buffer without glycosidase. None of the three glycosidases showed TK-like activity in the presence of the inhibitory cocktail.
Reversibility of Hyaluronidase Digestion
HA (10 g/ml; Fluka, Milwaukee, WI) was added to 100 l of a previously hyaluronidase-digested sample and incubated for 1 h at 37 Њ C. The resulting sample was used for TK activity measurement as well as visualization, using the overlay membrane method (35) .
Secretory Leukoprotease Inhibitor Levels
Secretory leukoprotease inhibitor (SLPI) was measured using an ELISA kit (R&D, Minneapolis, MN) according to the manufacturer's instructions.
Statistical Analysis
Data in the text and figures are expressed as means Ϯ standard error, or means Ϯ 95% confidence interval. The statistical significance of differences between means was determined by analysis of variance (ANOVA). P Ͻ 0.05 was considered significant. Linear regression was fit using SigmaPlot (Jandel Scientific, San Francisco, CA) and the correlation coefficient calculated using the method of least squares.
Results

Primary Cultures of Ovine Gland Cells Contain TK-Secreting Cells
We previously demonstrated increased TK activity in sheep BALF (23) (24) (25) (26) (27) after provocation. To confirm that the enzyme is synthesized and secreted by submucosal glands in the sheep respiratory tract, we localized TK by immunohistochemistry using commercially available antibodies to HUK that have been successfully used previously in sheep tissue for the labeling of salivary TK (36) . Airway tissues from trachea to fifth-generation bronchi showed positive labeling in the cells of the submucosal glands, but not in any surface epithelial cells (Figure 1 ). Morphology and staining with Alcian blue-periodic acid-Shiff (AB-PAS) suggested that its localization was limited to serous cells, as reported by Basbaum and associates (32) . These data are consistent with the reported localization of TK in human and guinea-pig airways (15, 16) , and suggest that cell cultures from submucosal glands could be used as an in vitro system to explore the regulation of TK activity.
Primary cultures of sheep tracheal submucosal tissue were prepared as described in M ATERIALS AND M ETHODS and stained with AB-PAS to determine the percentage of gland cells. After 10 d growth, 60 Ϯ 4% of cells stained positively with AB-PAS (100 cells were counted in each of five slides). To quantitate the fraction of cells expressing TK and to better assess the intracellular localization of TK, antibodies to HUK were used for immunofluorescence microscopy. The cultures showed that 41 Ϯ 23% (100 cells were counted in each of six slides) contained immunoreactive TK. Fluorescent staining was clearly observed in secretory granules of cells (Figure 2 ), confirming that submucosal gland cell cultures can be used to study TK regulation. The data also indicate that TK is packed in secretory granules, thus suggesting that TK could be released in response to secretagogue stimulation.
Chymase Stimulates Bronchial TK Secretion
To determine whether bronchial TK is regulated in a fashion similar to other secreted proteins of airway submucosal glands (e.g., lactoferrin, lysozyme, etc.), we treated cultures with chymase, a known potent secretagogue of respiratory tract glands (37) . As illustrated in Figure 3 , chymase (10 Ϫ 7 M) induced a significant increase ( P Ͻ 0.01, n ϭ 5) in the TK activity measured in the stimulated culture media (0.50 Ϯ 0.22 mU/ml), in comparison with the control group (0.08 Ϯ 0.02 mU/ml). Chymase stimulation also increased SLPI levels (a specific serous-cell product) (38) , and there was a significant positive correlation ( r ϭ 0.93) between TK activity and SLPI levels (Figure 4 ). The significant relationship between SLPI and TK secretion provided further evidence that TK was synthesized and secreted by serous cells and that its secretion was regulated in a fashion similar to other serous-cell products (32, 37) . Treatment of media obtained from unstimulated cell cultures with chymase (10 Ϫ 4 M) did not alter TK activity, showing that activation of prokallikrein by chymase was not responsible for the increases in TK activity observed after secretagogue stimulation. 
Bronchial TK Is Associated with Hyaluronic Acid
Anion exchange chromatography. To characterize the TK activity secreted by the cultures, the enzyme was concentrated and separated from media using anion exchange chromatography. TK activity eluted between 1.6 and 1.8 M NaCl with a minor peak observed at 0.3 M NaCl ( Figure  5 ). This finding differed from reports of pancreatic, urinary, and salivary kallikreins that eluted between 0.3 and 0.6 M NaCl under similar conditions (13, 39, 40) . Similar tight binding was observed using another anion exchange column (Hitrap Q Pharmacia; data not shown). One possible explanation for bronchial TK chromatographic behavior is that it was bound to a negatively charged molecule in this culture supernatant.
Glycosidase digestion. Submucosal glands produce a variety of negatively charged glycosaminoglycans (GAGs), such as HA and chondroitin sulfate (32, 41, 42) . To test whether such molecules were bound to TK in the culture media, we digested media with either hyaluronidase, chondroitinase ABC, or heparinase. Comparison of TK enzyme activity in the hyaluronidase-digested and untreated samples demonstrated that digestion dramatically increased bronchial TK activity from 0.23 Ϯ 0.02 to 19.81 Ϯ 3.65 mU/ml. Only hyaluronidase treatment caused a change in enzyme activity, while heparinase and chondroitinase treatment did not ( Figure 6 ). Hyaluronidase digestion of samples increased the TK activity in both unstimulated and chymase-stimulated samples (n ϭ 2, unstimulated from 0.04 Ϯ 0.01 to 0.26 Ϯ 0.03 mU/ml and postchymase from 0.32 Ϯ 0.08 to 0.52 Ϯ 0.02 mU/ml). Hyaluronidase digestion did not, however, change the magnitude of the increase in activity induced by chymase. To assess the effects of the digestion, samples of culture media were run on nondenaturing gels, and TK enzyme activity was visualized in the gel by a membrane-overlay technique. While recombinant HUK demonstrated a single sharp band of activity, undigested samples obtained from cultures showed a smear of activity consistent with numerous charged molecules having TK activity (this observation was also made in sheep unconcentrated tracheal lavage; data not shown). Only hyaluronidase digestion altered this pattern of TK activity in the gels, reducing the heterogeneity and average mobility of the TK-treated samples, whereas chondroitinase and heparinase digestion had no effect (Figure 7 ). Hyaluronidase digestion (3 h) increased TK activity, whereas longer digestion (18 h) completely reduced the heterogeneity and increased the electrophoretic mobility of bronchial TK to resemble that of recombinant HUK. This result could be reversed by adding HA to a hyaluronidase-digested sample, restoring the heterogeneity and reducing the TK activity (Figure 8b) .
These results were consistent with HA being the molecule that conferred the high negative charge to the TK eluted in the anion exchange chromatography, and suggest that HA binding altered the expression of TK catalytic activity.
Anion exchange chromatography of hyaluronidasedigested samples. The finding that hyaluronidase treatment resulted in a single band of enzyme activity suggests that anion exchange chromatography of hyaluronidasetreated samples would demonstrate a change in the elution position of TK. Hyaluronidase-digested conditioned media was applied to a UnoQ column, and chromatography was done as before. TK activity eluted as a single peak at about 0.35 M NaCl (Figure 7 ). This was consistent with the elution profile of other tissue kallikreins (40) , and confirmed the observation that hyaluronidase treatment alters the molecular nature of bronchial TK secreted by serousgland cells.
HA affinity chromatography. To confirm that bronchial TK specifically binds HA, undigested conditioned culture media were applied to a HA-Sepharose column. The majority of the enzyme activity in the sample (70%) bound to the column in 0.15 M NaCl, remained during 0.5 M NaCl washes, and eluted with 1 mg/ml HA in 0.5 M NaCl (Figure 9) . Equivalent samples, run on a heparin-Sepharose column, showed no binding of TK activity. The ability of TK to bind immobilized HA, and the fact that addition of HA to the elution buffer allowed TK recovery by competition, strongly suggest that TK is a HA binding protein.
Discussion
The results of this study show that bronchial TK binds to HA and that the association of TK with HA reduces TK activity. The response of submucosal gland cells to chy- mase stimulation indicates that bronchial TK is a regulated secretory product.
The immunolocalization of TK in submucosal glands of sheep trachea and bronchi is consistent with findings in human and guinea pig tissue (15, 16) and encouraged us to test cultures of these cells as an in vitro model to explore TK regulation. Submucosal gland cultures offered several advantages to study the behavior of TK. The culture media contained fewer proteins than did BALF, and many potential interactions of TK with serum-derived proteinase inhibitors present in BALF (e.g., protein C inhibitor, ␣ 2 macroglobulin, and ␣ 1 protease inhibitor) were avoided. In addition, the absence of inflammatory cells ruled out any contribution of neutrophil kallikrein to our measurement of TK activity.
The primary cultures used in this study were grown in the absence of retinoic acid to favor the serous secretory phenotype expression (43) and at confluence, 60% of the cells were secretory, as estimated by AB-PAS staining. Although our cultures had a mixed population of epithelial cells, TK immunolocalization in sheep airways is consistent with that reported for human and guinea pig trachea, which indicated that TK was localized in gland cells and that these cells were the source of the secreted enzyme in our primary cultures. Immunofluorescence of cultures showed that TK was packed in secretory granules, as reported for salivary and submaxillary glands (4, 5, 31, (44) (45) (46) (47) (48) . The positive correlation of released SLPI (a specific serous-cell marker) and TK provided further evidence that TK was synthesized by serous cells. When exposed to chymase for 1.5 h, our cultures showed an increase of TK activity. Media showed low levels of activity 24 h later, similar to the levels found before stimulation, probably reflecting constitutive release. Salivary kallikreins are reported to be secreted in both constitutive and regulated pathways (5, 46, 47, 49) ; our results suggest that this is also true for bronchial TK.
To characterize the TK activity, we used anion exchange chromatography as a first-step purification. Kallikreins have been purified from different exocrine tissues in various species using this approach, and typically showed an elution profile of simple or double peaks, between 0.3 and 0.6 M NaCl (13, 39, 40) . Our initial experiments showed a different profile, in which the main peak of TK activity eluted at high salt concentrations, suggesting that the enzyme had a much tighter binding with the anion exchange beads under these conditions. Possible explanations for this phenomena are: (1) the isoelectric point of this submucosal gland kallikrein was lower than previously reported (between 4 and 5); (2) we had identified a different enzyme expressing TK-like activity; or (3) the secreted bronchial TK was associated with a negatively charged molecule. The biochemical characteristics of the enzyme (K m and sensitivity to inhibitors, data not shown), the tissue localization, and its recognition by antibodies to HUK led us to test the third hypothesis. From the molecules secreted by submucosal gland cells, GAGs, such as heparin, chondroitin sulfate and HA, best suit these characteristics.
Digestion with hyaluronidase suggested that HA was responsible for bronchial TK behavior in anion exchange chromatography. Although digestion of HA could increase accessibility of the HA-derived anions to the support, the net number of HA charges present in the sample does not change after digestion and would not be expected to alter the elution of the enzyme on the basis of the capacity of the column. In addition, hyaluronidase-dependent alteration of TK activity and electrophoretic mobility was consistent with this concept. Addition of HA to digested samples restored the original electrophoretic heterogeneity, confirming the specificity of the hyaluronidase digestion and indicating that the pattern of TK electrophoretic mobility, observed in untreated samples, is due to HA association. Together, these data suggest that bronchial TK is a newly recognized HA binding protein.
In light of these results, we repeated secretagogue stimulation with chymase in a new batch of cells and compared the activities after hyaluronidase digestion. Hyaluronidase digestion increased the amount of TK activity almost identically in all samples (6-fold), whereas the differences before and after chymase remained constant (2-fold). This suggests that (1) HA content in the supernatant remained constant after chymase stimulation; (2) most of the TK present in the supernatant was bound to a large reservoir of HA; and (3) TK was a regulated product of these cultures. In these experiments, activation achieved by hyaluronidase was about 6-fold in contrast with the 19-fold obtained in the initial glycosidase digestion experiments (see RESULTS). It is not clear why this difference occurred, and we can only offer the following potential explanations to these differences: The changes in TK activity after hyaluronidase treatment is determined by both the total amount of TK and HA and the HA/TK ratio present in the supernatant. Little is known about the factors controlling the rate of HA degradation in the airways, but it is likely that factors degrading HA (including hyaluronidase) are produced by different epithelial cells. Therefore, the total amount of HA and TK, as well as their binding ratio, will depend on the percentage of different epithelial cells in culture. Since these are primary cell cultures, we have no control over this distribution, and these differences of the percentages of cells could easily account for the observed discrepancies. Obviously, variation in additional HA binding proteins in the culture (i.e, cell surface receptors such as CD44 or soluble binding proteins such as lactoferrin) can alter the binding ratio between TK and HA in an unpredictable manner.
Bronchial TK is secreted as a proenzyme, and a fraction of TK is present in BALF as prokallikrein. Whether HA is bound to kallikrein or prokallikrein could not be addressed in the present study because hyaluronidase digestion must be performed in the presence of protease inhibitors including SBTI, prohibiting proteolytic activation of prokallikrein. For this reason, the data refer only to the association of active TK with HA.
The biologic reason for bronchial TK to be bound to HA is not clear, but association of GAGs with proteases and protease inhibitors can regulate their functions by (1) immobilizing the enzyme, thereby restricting its range of action; (2) stearically blocking its activity; (3) providing a reservoir for delayed release; or (4) protecting it from proteolytic degradation (22, 50-55). These previously de-scribed functions of GAG-proteinase association could apply to bronchial TK-HA interactions. Here, we have shown that HA binding blocks TK enzyme activity. Many trypsin-like proteases, such as Cathepsin G, elastase, and tryptase, potentially can cleave TK. It is therefore also possible that HA binding could protect and increase the half-life of TK in the airways, thus serving as a reservoir for delayed release. HA has been reported to be elevated in BALF of patients with persistent asthma in comparison with normal or intermittent asthmatic subjects (56), indicating that HA turnover is, in fact, altered in these patients. No other kallikreins to our knowledge have been reported to bind GAGs, but it is possible that in secretions rich in HA (such as saliva or seminal fluid) TK, it is also associated with this GAG.
Hypersecretion is a common feature in airway diseases such as asthma, chronic bronchitis, bronchiectasis, and cystic fibrosis, and several products have the ability to induce submucosal gland secretion. Cell products (e.g., elastase from polymorphonuclear leukocytes and chymase from mast cells) (36, 42) , sensory nerve stimulation (through the release of neuropeptides such as substance P) (57) , and autonomic stimulation (mediated by muscarinic M 1 and M 3 receptors) (58) , are well characterized secretagogues. In light of our findings, all these mechanisms could be expected to increase TK release and, therefore, kinin generation when substrate is available, thus providing a positive stimulus for kinin-induced airway inflammation.
Studies by Christiansen and coworkers (17, 18) showed that TK is an important mediator in rhinitis and asthma. They also noted that bronchial TK was resistant in vitro to inhibition by most of the serine protease inhibitors present in BALF, suggesting that there was no effective inhibition for TK in the airways (59) . Although our own in vivo studies have identified potential inhibitors of TK activity, the studies described here clearly show that HA is an important and determining factor in the regulation of TK catalytic activity in the bronchial lumen. The mechanisms leading to TK upregulation during airway inflammation are unclear, and strategies to decrease its activity are important in defining its exact role in airway pathophysiology.
